AG˹ٷ

STOCK TITAN

[6-K] Haleon plc American Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary

Haleon plc (LSE/NYSE: HLN) filed a Form 6-K reporting progress on the share buyback programme announced 28 March 2025.

Daily trade: on 25 June 2025 the company repurchased 1,006,111 ordinary shares at a volume-weighted average price of 383.38 pence (high 384.80 p, low 380.70 p). All shares will be cancelled.

Completion of first tranche: Haleon has now finished the programme’s first tranche, acquiring 51,036,522 shares for an aggregate consideration of about £200 million. The tranche equates to roughly 0.6 % of the current share base.

Updated share capital: issued share capital is 8,988,533,553 shares of £0.01 each. After deducting 4,080,205 treasury shares, voting shares total 8,984,453,348. Investors should use this figure for FCA disclosure-threshold calculations.

Next steps: management will announce any further tranches separately. The filing contains no earnings, guidance, or operational updates.

Haleon plc (LSE/NYSE: HLN) ha presentato un modulo 6-K riportando i progressi sul programma di riacquisto azionario annunciato il 28 marzo 2025.

Operazioni giornaliere: il 25 giugno 2025 la società ha riacquistato 1.006.111 azioni ordinarie a un prezzo medio ponderato per volume di 383,38 pence (massimo 384,80 p, minimo 380,70 p). Tutte le azioni saranno cancellate.

Completamento della prima tranche: Haleon ha ora concluso la prima tranche del programma, acquisendo 51.036.522 azioni per un controvalore complessivo di circa 200 milioni di sterline. La tranche rappresenta circa lo 0,6% dell’attuale base azionaria.

Capitale sociale aggiornato: il capitale sociale emesso è di 8.988.533.553 azioni del valore nominale di £0,01 ciascuna. Dopo aver detratto 4.080.205 azioni proprie, le azioni con diritto di voto ammontano a 8.984.453.348. Gli investitori dovrebbero utilizzare questa cifra per i calcoli delle soglie di divulgazione FCA.

Prossimi passi: la direzione comunicherà separatamente eventuali ulteriori tranche. Il documento non contiene aggiornamenti su utili, previsioni o operazioni.

Haleon plc (LSE/NYSE: HLN) presentó un Formulario 6-K informando sobre el progreso del programa de recompra de acciones anunciado el 28 de marzo de 2025.

Operación diaria: el 25 de junio de 2025 la compañía recompró 1.006.111 acciones ordinarias a un precio medio ponderado por volumen de 383,38 peniques (máximo 384,80 p, mínimo 380,70 p). Todas las acciones serán canceladas.

Finalización del primer tramo: Haleon ha completado la primera fase del programa, adquiriendo 51.036.522 acciones por un importe total de aproximadamente 200 millones de libras. Este tramo representa aproximadamente el 0,6% de la base accionaria actual.

Capital social actualizado: el capital social emitido es de 8.988.533.553 acciones de £0,01 cada una. Tras deducir 4.080.205 acciones en autocartera, las acciones con derecho a voto suman 8.984.453.348. Los inversores deben usar esta cifra para los cálculos de umbrales de divulgación de la FCA.

Próximos pasos: la dirección anunciará cualquier tramo adicional por separado. El informe no contiene actualizaciones sobre ganancias, previsiones ni operaciones.

Haleon plc (LSE/NYSE: HLN)� 2025� 3� 28� 발표� 자사� 매입 프로그램� 진행 상황� 보고하는 Form 6-K� 제출했습니다.

일일 거래: 2025� 6� 25� 회사� 1,006,111주의 보통주를 가중평균가� 383.38펜스(최고 384.80펜스, 최저 380.70펜스)� 재매입했습니�. 모든 주식은 소각� 예정입니�.

� 번째 트랜� 완료: Haleon은 프로그램� � 번째 트랜치를 완료했으�, � � 2� 파운드에 해당하는 51,036,522주를 취득했습니다. � 트랜치는 현재 주식 총수� � 0.6%� 해당합니�.

업데이트� 자본�: 발행 주식 수는 � £0.01� 액면가� 가� 8,988,533,553주입니다. 4,080,205주의 자사주를 차감� � 의결� 있는 주식 수는 8,984,453,348주입니다. 투자자들은 FCA 공시 임계� 계산 � � 수치� 사용해야 합니�.

향후 계획: 경영진은 추가 트랜치가 있을 경우 별도� 발표� 예정입니�. 이번 제출 서류에는 수익, 가이드라인 또는 운영 관� 업데이트� 포함되어 있지 않습니다.

Haleon plc (LSE/NYSE : HLN) a déposé un formulaire 6-K rapportant les progrès du programme de rachat d’actions annoncé le 28 mars 2025.

Transactions quotidiennes : le 25 juin 2025, la société a racheté 1 006 111 actions ordinaires à un prix moyen pondéré en fonction du volume de 383,38 pence (haut 384,80 p, bas 380,70 p). Toutes les actions seront ԲԳܱé.

Achèvement de la première tranche : Haleon a maintenant terminé la première tranche du programme, acquérant 51 036 522 actions pour une contrepartie totale d’environ 200 millions de livres sterling. Cette tranche représente environ 0,6 % de la base d’actions actuelle.

Capital social mis à jour : le capital social émis s’élève à 8 988 533 553 actions de 0,01 £ chacune. Après déduction de 4 080 205 actions propres, le nombre d’actions avec droit de vote est de 8 984 453 348. Les investisseurs doivent utiliser ce chiffre pour les calculs des seuils de divulgation FCA.

Prochaines étapes : la direction annoncera séparément toute tranche supplémentaire. Le dépôt ne contient aucune mise à jour sur les bénéfices, les prévisions ou les opérations.

Haleon plc (LSE/NYSE: HLN) hat ein Formular 6-K eingereicht, das den Fortschritt des am 28. März 2025 angekündigten Aktienrückkaufprogramms meldet.

ղäڳ: Am 25. Juni 2025 hat das Unternehmen 1.006.111 Stammaktien zu einem volumengewichteten Durchschnittspreis von 383,38 Pence (Hoch 384,80 p, Tief 380,70 p) zurückgekauft. Alle Aktien werden annulliert.

Abschluss der ersten Tranche: Haleon hat die erste Tranche des Programms abgeschlossen und 51.036.522 Aktien für insgesamt rund 200 Millionen Pfund erworben. Die Tranche entspricht etwa 0,6 % des aktuellen Aktienbestands.

Aktualisiertes Grundkapital: Das ausgegebene Grundkapital beträgt 8.988.533.553 Aktien mit einem Nennwert von je £0,01. Nach Abzug von 4.080.205 eigenen Aktien beläuft sich die Anzahl der stimmberechtigten Aktien auf 8.984.453.348. Investoren sollten diese Zahl für die Berechnung von FCA-Offenlegungsschwellen verwenden.

Nächste Schritte: Das Management wird weitere Tranchen gesondert bekannt geben. Die Einreichung enthält keine Angaben zu Gewinnen, Prognosen oder operativen Updates.

Positive
  • £200 million of capital returned to shareholders via completed first-tranche buyback.
  • Cancellation of 51 million shares delivers slight EPS accretion and signals management’s confidence in intrinsic value.
Negative
  • Buyback reduces share count by only ~0.6 %, offering limited near-term financial impact.

Insights

TL;DR Minor buyback tranche completed; £200 m spent, <0.6 % share reduction—signal of confidence but limited earnings impact.

The first £200 million tranche of Haleon’s March-announced buyback is now complete, bringing cumulative repurchases to 51 million shares—about 0.6 % of the 8.99 billion shares outstanding. While returning cash is shareholder-friendly and marginally accretive to EPS, the scale is modest relative to Haleon’s market capitalisation and free-cash-flow profile. Completion removes an overhang of daily trading but does not materially change leverage or capital allocation flexibility. Future tranches, if sized meaningfully, could influence valuation; however, today’s disclosure is routine, regulatory in nature, and not expected to shift the investment thesis materially.

Haleon plc (LSE/NYSE: HLN) ha presentato un modulo 6-K riportando i progressi sul programma di riacquisto azionario annunciato il 28 marzo 2025.

Operazioni giornaliere: il 25 giugno 2025 la società ha riacquistato 1.006.111 azioni ordinarie a un prezzo medio ponderato per volume di 383,38 pence (massimo 384,80 p, minimo 380,70 p). Tutte le azioni saranno cancellate.

Completamento della prima tranche: Haleon ha ora concluso la prima tranche del programma, acquisendo 51.036.522 azioni per un controvalore complessivo di circa 200 milioni di sterline. La tranche rappresenta circa lo 0,6% dell’attuale base azionaria.

Capitale sociale aggiornato: il capitale sociale emesso è di 8.988.533.553 azioni del valore nominale di £0,01 ciascuna. Dopo aver detratto 4.080.205 azioni proprie, le azioni con diritto di voto ammontano a 8.984.453.348. Gli investitori dovrebbero utilizzare questa cifra per i calcoli delle soglie di divulgazione FCA.

Prossimi passi: la direzione comunicherà separatamente eventuali ulteriori tranche. Il documento non contiene aggiornamenti su utili, previsioni o operazioni.

Haleon plc (LSE/NYSE: HLN) presentó un Formulario 6-K informando sobre el progreso del programa de recompra de acciones anunciado el 28 de marzo de 2025.

Operación diaria: el 25 de junio de 2025 la compañía recompró 1.006.111 acciones ordinarias a un precio medio ponderado por volumen de 383,38 peniques (máximo 384,80 p, mínimo 380,70 p). Todas las acciones serán canceladas.

Finalización del primer tramo: Haleon ha completado la primera fase del programa, adquiriendo 51.036.522 acciones por un importe total de aproximadamente 200 millones de libras. Este tramo representa aproximadamente el 0,6% de la base accionaria actual.

Capital social actualizado: el capital social emitido es de 8.988.533.553 acciones de £0,01 cada una. Tras deducir 4.080.205 acciones en autocartera, las acciones con derecho a voto suman 8.984.453.348. Los inversores deben usar esta cifra para los cálculos de umbrales de divulgación de la FCA.

Próximos pasos: la dirección anunciará cualquier tramo adicional por separado. El informe no contiene actualizaciones sobre ganancias, previsiones ni operaciones.

Haleon plc (LSE/NYSE: HLN)� 2025� 3� 28� 발표� 자사� 매입 프로그램� 진행 상황� 보고하는 Form 6-K� 제출했습니다.

일일 거래: 2025� 6� 25� 회사� 1,006,111주의 보통주를 가중평균가� 383.38펜스(최고 384.80펜스, 최저 380.70펜스)� 재매입했습니�. 모든 주식은 소각� 예정입니�.

� 번째 트랜� 완료: Haleon은 프로그램� � 번째 트랜치를 완료했으�, � � 2� 파운드에 해당하는 51,036,522주를 취득했습니다. � 트랜치는 현재 주식 총수� � 0.6%� 해당합니�.

업데이트� 자본�: 발행 주식 수는 � £0.01� 액면가� 가� 8,988,533,553주입니다. 4,080,205주의 자사주를 차감� � 의결� 있는 주식 수는 8,984,453,348주입니다. 투자자들은 FCA 공시 임계� 계산 � � 수치� 사용해야 합니�.

향후 계획: 경영진은 추가 트랜치가 있을 경우 별도� 발표� 예정입니�. 이번 제출 서류에는 수익, 가이드라인 또는 운영 관� 업데이트� 포함되어 있지 않습니다.

Haleon plc (LSE/NYSE : HLN) a déposé un formulaire 6-K rapportant les progrès du programme de rachat d’actions annoncé le 28 mars 2025.

Transactions quotidiennes : le 25 juin 2025, la société a racheté 1 006 111 actions ordinaires à un prix moyen pondéré en fonction du volume de 383,38 pence (haut 384,80 p, bas 380,70 p). Toutes les actions seront ԲԳܱé.

Achèvement de la première tranche : Haleon a maintenant terminé la première tranche du programme, acquérant 51 036 522 actions pour une contrepartie totale d’environ 200 millions de livres sterling. Cette tranche représente environ 0,6 % de la base d’actions actuelle.

Capital social mis à jour : le capital social émis s’élève à 8 988 533 553 actions de 0,01 £ chacune. Après déduction de 4 080 205 actions propres, le nombre d’actions avec droit de vote est de 8 984 453 348. Les investisseurs doivent utiliser ce chiffre pour les calculs des seuils de divulgation FCA.

Prochaines étapes : la direction annoncera séparément toute tranche supplémentaire. Le dépôt ne contient aucune mise à jour sur les bénéfices, les prévisions ou les opérations.

Haleon plc (LSE/NYSE: HLN) hat ein Formular 6-K eingereicht, das den Fortschritt des am 28. März 2025 angekündigten Aktienrückkaufprogramms meldet.

ղäڳ: Am 25. Juni 2025 hat das Unternehmen 1.006.111 Stammaktien zu einem volumengewichteten Durchschnittspreis von 383,38 Pence (Hoch 384,80 p, Tief 380,70 p) zurückgekauft. Alle Aktien werden annulliert.

Abschluss der ersten Tranche: Haleon hat die erste Tranche des Programms abgeschlossen und 51.036.522 Aktien für insgesamt rund 200 Millionen Pfund erworben. Die Tranche entspricht etwa 0,6 % des aktuellen Aktienbestands.

Aktualisiertes Grundkapital: Das ausgegebene Grundkapital beträgt 8.988.533.553 Aktien mit einem Nennwert von je £0,01. Nach Abzug von 4.080.205 eigenen Aktien beläuft sich die Anzahl der stimmberechtigten Aktien auf 8.984.453.348. Investoren sollten diese Zahl für die Berechnung von FCA-Offenlegungsschwellen verwenden.

Nächste Schritte: Das Management wird weitere Tranchen gesondert bekannt geben. Die Einreichung enthält keine Angaben zu Gewinnen, Prognosen oder operativen Updates.

UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of June 2025
 
Commission File Number: 001-41411
 
Haleon plc
(Translation of registrant’s name into English)
 
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address of principal executive offices)
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
 
 
Form 20-F
 
Form 40-F
 
 
 
EXHIBIT INDEX
 
Exhibit Number
Description
99.1
26 June 2025 - “Transaction in Own Shares”
 
 
99.1
 
 
 
Haleon plc: Transaction in own shares and update on the Buyback Programme
 
26 June 2025: Haleon plc (the "Company" or "Haleon") today announces the purchase of the following number of ordinary shares of £0.01 each in the Company (the "Shares") for cancellation under its share buyback programme announced on 28 March 2025 (the "Buyback Programme").
 
 
Date of purchase:
25 June 2025
Number of Shares purchased:
1,006,111
Highest price paid per share (p):
384.80
Lowest price paid per share (p):
380.70
Volume weighted average price paid per share (p):
383.38

 
Following the settlement of the above, the Company's registered share capital is 8,988,533,553 ordinary shares of £0.01 each, of which 4,080,205 are held as treasury shares. Therefore, the number of ordinary shares with voting rights is 8,984,453,348 and this figure may be used by shareholders to determine if they are required to notify their interest, or a change to their interest, in Haleon under the FCA's Disclosure Guidance and Transparency Rules.
 
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), a full breakdown of the individual trades is available at the link below:
 
http://www.rns-pdf.londonstockexchange.com/rns/4578O_1-2025-6-25.pdf
 
This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.
 
This announcement and individual trade breakdown will also be available on the Company's website at: www.haleon.com/investors.
 
Completion of First Tranche of the Buyback Programme
Following the above transaction, Haleon has completed the First Tranche of the Buyback Programme. In total, the Company repurchased 51,036,522 Shares, all of which were cancelled, for an aggregate consideration of c. £200m.
 
Any further tranches of the Buyback Programme will be announced in due course.
 
 
Enquiries
 
Investors
 
Media
 
Jo Russell
+44 7787 392441
Zoë Bird
+44 7736 746167
Rakesh Patel
+44 7552 484646
Victoria Durman
+44 7894 505730
Emma White
+44 7823 523562
 
 
 
 
 
 
 
 
About Haleon
Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.
 
For more information, please visit www.haleon.com.
 
 
 
 
 
 
 
 
 
SIGNATURE
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
HALEON PLC
(Registrant)
 
Date: June 26, 2025
By:
/s/ Amanda Mellor
 
 
Name:
Amanda Mellor
 
 
Title:
Company Secretary

FAQ

How many Haleon (HLN) shares were repurchased on 25 June 2025?

1,006,111 ordinary shares were bought at a VWAP of 383.38 p.

What is the total value of Haleon's completed first buyback tranche?

The company spent approximately £200 million to repurchase 51,036,522 shares.

What is Haleon's updated share count with voting rights?

After cancellations, voting shares stand at 8,984,453,348.

Will Haleon launch additional share repurchase tranches?

Management stated that any further tranches will be announced in due course.

Does the 6-K include any earnings or guidance updates?

No. The filing is limited to share buyback activity and capital structure data.
Haleon

NYSE:HLN

HLN Rankings

HLN Latest News

HLN Latest SEC Filings

HLN Stock Data

46.81B
4.49B
0.02%
11.99%
0.59%
Drug Manufacturers - Specialty & Generic
Healthcare
United Kingdom
Weybridge